EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Seminar ER1 – Hospital pharmacy practice research: why and how to be more engaged and publish?
Leiden University Medical Center, Clinical Pharmacy&Toxicology - Hospital Pharmacist
The Netherlands
1. Current Status, Position
Dr. Paul P.H. Le Brun is currently hospital Pharmacist-clinical pharmacologist. As head QA/QP responsible for the quality of production and trials medication. As associate-professor teaching students in production and quality at university of Leiden.
2. Education
Dr. Paul PH Le Brun obtained his degree in pharmacy from the Groningen University in 1982. He started his career at the Dutch Laboratory of Pharmacists (LNA), department of the Royal Dutch Association of Pharmacists (KNMP) from 1982 until 1985. The LNA supports Dutch local and hospital pharmacists with the preparation of medicines.
From 1985 until1988 he was trained and worked as a hospital pharmacist in the Central Hospital Pharmacy of The Hague.
He joined Merck Sharp & Dohme as production pharmacist from 1989 to 1992. GMP implementation, troubleshooting, training of personnel and product and process validation were his main responsibilities.
From 1992 until 2017 he was director of production of the Central Hospital Pharmacy in The Hague, where he was responsible for all production activities, including management, product development, product and process validation and renovation of premises. This position was combined with clinical tasks in Bronovo and Haga teaching hospital, respectively.
January 2017 he was appointed as head QA and Qualified Person at the department clinical pharmacology and toxicology of the Leiden University Medical Centre where he is also associate professor GMP.
In 2001 he obtained his Ph.D on the improvement and development of antibiotic inhalation for CF patients. The title of his thesis reads: “Optimization of antibiotic inhalation therapy in Cystic Fibrosis. Studies on nebulized tobramycin. Development of colistin dry powder inhaler system”. In 2001 he also received the innovation award of the Royal Dutch Society of Pharmacists for his research. He further specialized as clinical pharmacologist in 2002.
From 2007 until 2012, he was a member of the board of the Dutch Society of Hospital Pharmacists (NVZA) with the area of attention: production, QC and QA policy regarding hospital pharmacy in the Netherlands. To date he is one of the Dutch delegates for the General Assembly of the European Association of Hospital Pharmacists.
In 2009 he was one of the editors of Recepteerkunde, a Dutch standard textbook on pharmacy products and preparations and also of the follow up, the international equivalent ‘Practical Pharmaceutics’, which came available in 2015. Paul is chief editor of the second edition which will come available in 2022.
3. Research Area
Main Research Themes:
Aseptic preparation parenteral drugs
Medicinal product development
Theses:
Supervision of PhD project: Sterility assurance of aseptic handling in hospital pharmacies. Frits Boom. To be finalised in 2022
Local, National and International Research Collaborations:
Academic Pharma LUMC
GERPAC (France) Microbiological Shelf-life for Hospital Pharmacy Aseptic Preparations
4. Conflict of interest
No conflict of interest declared.
